## Abstract ## BACKGROUND. Matrix metalloproteinases (MMPs) are overexpressed in Kaposi sarcoma (KS). The safety and efficacy of a novel, orally bioavailable MMP inhibitor, BMSβ275291, was evaluated in patients with human immunodeficiency virusβassociated KS and the correlation between changes in
β¦ LIBER β¦
Antibody specificity for human immunodeficiency virus type 1 in serum and cerebrospinal fluid from patients with AIDS and AIDS-related complex
β Scribed by P. B. Willoughby; J. S. Midgett; J. D. Folds
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 960 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Phase 1/2 trial of BMS-275291 in patient
β
Brett T. Brinker; Susan E. Krown; Jeannette Y. Lee; Ethel Cesarman; Amy Chadburn
π
Article
π
2008
π
John Wiley and Sons
π
English
β 85 KB
More reliable diagnosis of infection wit
β
Seiichi Hashida; Kazuya Hashinaka; Setsuko Ishikawa; Eiji Ishikawa
π
Article
π
1997
π
John Wiley and Sons
π
English
β 329 KB
π 1 views
Erratum: Hashida S, Hashinaka K, Ishikaw
π
Article
π
1998
π
John Wiley and Sons
π
English
β 7 KB
π 2 views
More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassa